JPRN-jRCT2080222963未知3 期
Phase 3 study of KHK7580 (A Long-term Study of KHK7580 in Subjects with Secondary Hyperparathyroidism Receiving Hemodialysis)
Kyowa Hakko Kirin Co., Ltd.0 个研究点目标入组 120 人开始时间: 2015年9月10日最近更新:
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Personally submitted written voluntary informed consent to participate in the study
- •- Stable chronic renal disease treated with hemodialysis 3 times weekly for at least 12 weeks before screening
- •- Intact parathyroid hormone (PTH) level of > 240 pg/ml at screening (except subjects receiving cinacalcet hydrochroride at screening)
排除标准
- 未提供
研究者
相似试验
未知
3 期
Phase 3 study of KHK7580Secondary hyperparathyroidism receiving peritoneal dialysisJPRN-jRCT2080222964Kyowa Hakko Kirin Co., Ltd.30
未知
3 期
Phase 3 double-blind study of KHK7580JPRN-jRCT2080222961Kyowa Hakko Kirin Co., Ltd.600
已完成
3 期
Phase 3 Study of KHK7580Secondary HyperparathyroidismNCT02549404Kyowa Kirin Co., Ltd.137
已完成
3 期
Phase 3 Study of KHK7580Secondary HyperparathyroidismNCT02549417Kyowa Kirin Co., Ltd.39
已完成
2 期
Phase 3 Study of KHK7580Secondary HyperparathyroidismNCT02549391Kyowa Kirin Co., Ltd.634